EUVIMEDEUVIMED entdecken
Open Access

Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database

Andrew C Birkeland, Andrew J Rosko, Steven B Chinn, Mark E Prince, Gordon H Sun, Matthew E Spector

ORL · 2016 · 78 (2) · 61-69

DOI: 10.1159/000443768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ORL, online erschienen am 25.02.2016. Verfasst von Andrew C Birkeland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Mich., USA. Hauptthemen laut MEDLINE: Neoplasm Staging, SEER Program. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Patients with head and neck squamous cell carcinoma (HNSCC) are at risk for second primary malignancies (SPMs). The prevalence, distribution, and patient survival in head and neck versus non-head and neck SPMs are not fully elucidated. The objective of this study was to quantify the rate of SPMs in patients with HNSCC.

Methods

This is a population-based cohort study using the Surveillance, Epidemiology, and End Results (SEER) database. Prevalence and location of SPMs, and survival data were analyzed.

Results

There were 58,363 HNSCC patients, and the prevalence of HNSCC and non-HNSCC SPMs was 3.0% (1,746) and 8.8% (5,109), respectively. Overall survival (OS) was higher in patients with HNSCC SPMs compared to non-HNSCC SPMs (p < 0.001), with no difference in disease-specific survival. Patients with SPMs in the lung and esophagus had a worse OS (p < 0.001), and patients with SPMs in the prostate and breast had a better OS (p < 0.001).

Conclusion

In HNSCC patients who develop SPMs, nearly 75% are non-HNSCC SPMs. Patients with non-HNSCC SPMs have a lower OS. Future clinical practice guidelines should take the risks and locations of SPM development into consideration for screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm StagingSEER ProgramAgedCarcinoma, Squamous CellFemaleFollow-Up StudiesHead and Neck NeoplasmsHumansMaleMiddle AgedNeoplasms, Second PrimaryPrevalenceRetrospective StudiesRisk AssessmentRisk FactorsSquamous Cell Carcinoma of Head and NeckSurvival RateUnited States

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Mich., USA.

Förderung

  • NIDCD NIH HHS

Zitieren

APA

Birkeland, A. C., Rosko, A. J., Chinn, S. B., Prince, M. E., Sun, G. H., & Spector, M. E. (2016). Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. ORL, 78(2), 61-69. https://doi.org/10.1159/000443768

Vancouver

Birkeland AC, Rosko AJ, Chinn SB, Prince ME, Sun GH, Spector ME. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. ORL. 2016;78(2):61-69. doi:10.1159/000443768

BibTeX
@article{Birkeland2016,
  author = {Birkeland, Andrew C and Rosko, Andrew J and Chinn, Steven B and Prince, Mark E and Sun, Gordon H and Spector, Matthew E},
  title = {Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database},
  journal = {ORL},
  year = {2016},
  volume = {78},
  number = {2},
  pages = {61--69},
  doi = {10.1159/000443768}
}
Kostenlos starten →